Radium-223-chloride
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Radium-223-chloride, covering 2020-11-17 to 2022-09-29. Get the full timeline:
Most recent: Clinical Trial Update: A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer [Phase 2]